Company intelligence / Profile preview

Advanced BioSurface

Minnetonka, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Advanced BioSurface was a medical device company specializing in the development of minimally invasive orthopedic implants and biomaterials for joint repair. The company's lead product, the OrthoGlide Medial Knee System, was designed as a bone-sparing treatment for patients with medial compartment osteoarthritis, offering an alternative to total knee arthroplasty. Additionally, the company worked on synthetic cartilage technologies to address articular cartilage defects. In 2008, Advanced BioSurface was acquired by Zimmer Holdings, which integrated the company's joint preservation technologies into its orthopedic portfolio.

Therapeutic areas: Rheumatology
Modalities: DeviceBiomaterial
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Advanced BioSurface.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced BioSurface.

Explore the full profile